Ra Capital Management, L.P. Dice Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $26.3 Million - $32.6 Million	1,007,701 Added 14.71%	7,856,612 $225 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $32.4 Million - $69.3 Million	1,640,000 Added 31.48%	6,848,911 $214 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $166 Million - $193 Million	5,208,911 New	5,208,911 $171 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.